查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1784049

全球预防保健技术与服务市场

Preventive Healthcare Technologies and Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球预防保健技术和服务市场规模将达到 5.211 亿美元

全球预防性医疗保健技术和服务市场规模预计在2024年为2.979亿美元，到2030年将达到5.211亿美元，2024年至2030年的复合年增长率为9.8%。早期检测和筛检技术是本报告分析的细分市场之一，预计其复合年增长率为8.8%，到分析期结束时规模将达到1.997亿美元。慢性病管理技术细分市场在分析期间的复合年增长率预计为8.9%。

美国市场规模估计为 8,120 万美元，中国市场预计复合年增长率为 13.2%

美国预防保健技术和服务市场规模预计在2024年达到8,120万美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.052亿美元，在2024-2030年的分析期间内，复合年增长率为13.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为7.1%和8.5%。在欧洲，预计德国市场的复合年增长率为7.6%。

全球预防保健技术和服务市场—主要趋势和驱动因素摘要

为什么预防性医疗保健在全球医疗产业中越来越受到重视？

随着医疗保健系统转向预防措施以减轻疾病负担、改善患者预后并降低医疗成本，预防性医疗保健技术和服务正在经历显着增长。与专注于治疗疾病的被动式医疗保健模式不同，预防性医疗保健强调早期诊断、风险评估和生活方式的改变，以预防糖尿病、心血管疾病和癌症等慢性疾病。随着文明病的日益普遍，政府、保险公司和医疗保健提供者正在优先考虑预防策略，例如疫苗接种计划、早期筛检工具和个人化健康监测解决方案。数位健康平台、穿戴式装置和人工智慧主导的诊断技术的兴起，进一步提高了预防保健的可近性和准确性。消费者也越来越注重健康，接受以健康为中心的行为，并利用科技追踪和管理自己的健康状况。随着公共和私营医疗保健部门持续投资于预防措施，全球预防性医疗保健技术和服务市场将不断扩大，并重塑医疗保健服务的未来。

哪些挑战阻碍了预防性医疗保健的发展？

儘管预防性医疗保健技术有许多好处，但其广泛应用仍面临多重挑战。其中一个主要障碍是先进诊断工具和健康筛检服务的成本，并非所有人都能负担得起，尤其是低收入者。由于缺乏标准的预防性医疗保健政策和报销机制，保险公司往往优先考虑治疗而非预防，这进一步限制了人们获得预防性医疗保健的机会。此外，患者对预防性医疗保健措施的依从性仍然令人担忧，因为许多患者会推迟筛检、忽视早期症状或放弃定期身体检查。跨平台整合预防性医疗保健数据的复杂性也给医疗保健提供者带来了挑战，因为他们必须解决电子健康记录(EHR)、数位健康设备和人工智慧主导分析之间的互通性问题。此外，围绕疫苗、预防性药物和数位健康监测的错误讯息和怀疑可能会减缓市场渗透。应对这些挑战需要加强政府支持力度、进行公众意识提升宣传活动，以及技术提供者和医疗保健组织之间的策略合作。

科技进步将如何增强预防性医疗保健？

技术创新处于预防性医疗革命的前沿，使更准确、更有效率、更个人化的健康介入成为可能。人工智慧和巨量资料分析的整合正在改善疾病预测模型，使医疗专业人员能够识别高风险族群并实施早期疗育策略。穿戴式健康追踪器和智慧医疗设备使消费者能够监测心率、血压和血糖水平等关键健康指标，为预防保健提供即时回馈。远端医疗和数位健康平台透过促进远距咨询、数位健康指导和人工智慧主导的诊断，进一步扩大了预防服务的覆盖范围。基因组医学和预测性生物标记分析正在透过识别遗传倾向来彻底改变个人化医疗，从而实现量身定制的预防策略。此外，人们正在探索利用区块链技术实现安全的医疗数据共用，在确保患者隐私的同时改进数据主导的预防性医疗解决方案。随着这些技术的不断发展，预防性医疗将变得更加有效、更具成本效益，并被世界各地的人们广泛普及。

是什么推动了预防性医疗技术和服务市场的成长？

预防性医疗保健技术与服务市场的成长受到多种因素的推动，包括人们对慢性病预防意识的不断提高、诊断技术的进步以及数位健康解决方案的扩展。穿戴式医疗技术和人工智慧预测分析的日益普及，正在加速对个人化预防性医疗保健的需求。政府推行的早期疾病检测和疫苗接种计画的政策正在进一步推动市场扩张，尤其是在医疗基础设施完善的已开发地区。企业部门也为成长做出了贡献，雇主们投资于健康计画和预防性体检，以增强员工的健康和生产力。此外，将远端医疗服务融入预防性医疗保健策略正在提高医疗服务的可近性，尤其是对于偏远地区服务不足的人而言。随着医疗保健提供者、支付方和消费者不断认识到预防性医疗保健的长期益处，预计该市场将持续增长，并改变全球健康和保健的管理方式。

部分

按类型（早期检测/筛检技术、慢性病管理技术、疫苗、其他类型）

受访公司范例

  • Abbott Laboratories
  • Cerner Corporation
  • Cigna
  • Epic Systems Corporation
  • GlaxoSmithKline plc（GSK）
  • Health Catalyst
  • IBM Watson Health
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co., Inc.
  • Myriad Genetics
  • NovX Systems Corp.
  • Omron Healthcare, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi
  • Siemens Healthineers
  • Teladoc Health
  • UnitedHealth Group

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP32689

Global Preventive Healthcare Technologies and Services Market to Reach US$521.1 Million by 2030

The global market for Preventive Healthcare Technologies and Services estimated at US$297.9 Million in the year 2024, is expected to reach US$521.1 Million by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Early Detection & Screening Technologies, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$199.7 Million by the end of the analysis period. Growth in the Chronic Disease Management Technologies segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$81.2 Million While China is Forecast to Grow at 13.2% CAGR

The Preventive Healthcare Technologies and Services market in the U.S. is estimated at US$81.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Preventive Healthcare Technologies and Services Market - Key Trends & Drivers Summarized

Why Is Preventive Healthcare Gaining Momentum in the Global Medical Industry?

Preventive healthcare technologies and services have witnessed substantial growth as healthcare systems shift toward proactive measures to reduce disease burden, improve patient outcomes, and lower medical costs. Unlike reactive healthcare models that focus on treating illnesses, preventive healthcare emphasizes early diagnosis, risk assessment, and lifestyle modifications to prevent chronic diseases such as diabetes, cardiovascular disorders, and cancer. With the increasing prevalence of lifestyle-related diseases, governments, insurers, and healthcare providers are prioritizing preventive strategies, including vaccination programs, early screening tools, and personalized health monitoring solutions. The rise of digital health platforms, wearable devices, and artificial intelligence-driven diagnostics has further enhanced the accessibility and accuracy of preventive healthcare. Consumers are also becoming more health-conscious, adopting wellness-focused behaviors and leveraging technology to track and manage their health. As public and private healthcare sectors continue investing in preventive measures, the global market for preventive healthcare technologies and services is set to expand, reshaping the future of healthcare delivery.

What Challenges Are Hindering the Growth of Preventive Healthcare?

Despite its advantages, the widespread adoption of preventive healthcare technologies faces multiple challenges. One of the primary barriers is the cost of advanced diagnostic tools and health screening services, which may not be affordable for all populations, particularly in low-income regions. The lack of standardized policies and reimbursement structures for preventive healthcare further limits its accessibility, as insurance providers often prioritize treatment over prevention. Additionally, patient adherence to preventive healthcare measures remains a concern, as many individuals delay screenings, ignore early symptoms, or fail to maintain regular health check-ups. The complexity of integrating preventive healthcare data across multiple platforms also presents challenges for healthcare providers, as interoperability issues between electronic health records (EHRs), digital health devices, and AI-driven analytics must be addressed. Moreover, misinformation and skepticism surrounding vaccines, preventive medications, and digital health monitoring can slow market penetration. Addressing these challenges requires increased government support, public awareness campaigns, and strategic collaborations between technology providers and healthcare institutions.

How Are Technological Advancements Enhancing Preventive Healthcare?

Technological innovation is at the forefront of the preventive healthcare revolution, enabling more precise, efficient, and personalized health interventions. The integration of artificial intelligence and big data analytics is improving disease prediction models, allowing healthcare professionals to identify high-risk individuals and implement early intervention strategies. Wearable health trackers and smart medical devices are empowering consumers to monitor key health metrics such as heart rate, blood pressure, and glucose levels, providing real-time feedback for preventive care. Telemedicine and digital health platforms are further expanding access to preventive services by facilitating remote consultations, digital health coaching, and AI-driven diagnostics. Genomic medicine and predictive biomarker analysis are revolutionizing personalized healthcare by identifying genetic predispositions to diseases, enabling tailored prevention strategies. Additionally, blockchain technology is being explored for secure health data sharing, ensuring patient privacy while improving data-driven preventive healthcare solutions. As these technologies continue to evolve, preventive healthcare will become more effective, cost-efficient, and widely accessible across global populations.

What Is Driving the Growth of the Preventive Healthcare Technologies and Services Market?

The growth in the preventive healthcare technologies and services market is driven by several factors, including increasing awareness of chronic disease prevention, advancements in diagnostic technologies, and the expansion of digital health solutions. The rising adoption of wearable health technology and AI-powered predictive analytics is accelerating the demand for personalized preventive care. Government policies promoting early disease detection and vaccination programs are further supporting market expansion, particularly in developed regions with strong healthcare infrastructure. The corporate sector is also contributing to growth, with employers investing in wellness programs and preventive screenings to enhance workforce health and productivity. Additionally, the integration of telehealth services into preventive care strategies is improving accessibility, particularly for remote and underserved populations. As healthcare providers, insurers, and consumers continue to recognize the long-term benefits of preventive healthcare, the market is expected to witness sustained growth, transforming the way health and wellness are managed globally.

SCOPE OF STUDY:

The report analyzes the Preventive Healthcare Technologies and Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Cerner Corporation
  • Cigna
  • Epic Systems Corporation
  • GlaxoSmithKline plc (GSK)
  • Health Catalyst
  • IBM Watson Health
  • Johnson & Johnson
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co., Inc.
  • Myriad Genetics
  • NovX Systems Corp.
  • Omron Healthcare, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi
  • Siemens Healthineers
  • Teladoc Health
  • UnitedHealth Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Preventive Healthcare Technologies and Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Chronic Diseases Throws the Spotlight on Proactive Risk Mitigation and Health Monitoring
    • Expansion of Digital Health Ecosystems Drives Adoption of Remote Preventive Screening and Health Management Services
    • Integration of AI and Predictive Analytics in Early Detection Platforms Strengthens Business Case for Risk-Based Interventions
    • Growth in Wearable Devices and Mobile Health Apps Spurs Continuous Personal Health Data Collection and Monitoring
    • Government-Led Public Health Campaigns and Incentives Propel Mass Adoption of Preventive Care Solutions
    • Rising Consumer Awareness Around Preventive Health and Wellness Drives Demand for Personalized Diagnostic Services
    • Increasing Penetration of Telemedicine and Virtual Consultations Expands Access to Preventive Health Technologies
    • Development of Integrated Health Information Platforms Accelerates Interoperability and Coordinated Preventive Care
    • Focus on Value-Based Healthcare Models Drives Investments in Preventive Rather Than Reactive Treatment Approaches
    • Emergence of At-Home Testing Kits and Point-of-Care Devices Generates Demand for Decentralized Screening Programs
    • Adoption of Population Health Management Platforms Expands Addressable Market for Enterprise-Scale Preventive Solutions
    • Shift Toward Genomic and Epigenetic Risk Profiling Spurs Growth in Predictive Preventive Diagnostics
    • Increased Emphasis on Immunization and Vaccine Management Strengthens Role of Preventive Services in Public Health
    • Expansion of Corporate Wellness Programs and Employee Health Benefits Drives Organizational Investments in Preventive Care
    • Growth in AI-Powered Chatbots and Virtual Coaches Enhances Patient Engagement in Preventive Health Routines
    • Regulatory Push for Preventive Screening Guidelines and Early Detection Protocols Drives Clinical Implementation
    • Integration of Behavioral and Mental Health Modules into Preventive Platforms Spurs Holistic Health Management
    • Increased Use of Cloud-Based Analytics Enhances Risk Prediction Models and Personalized Preventive Treatment Plans
    • Partnerships Between Tech Firms and Healthcare Providers Propel Innovation in Digital Preventive Health Solutions
    • Rising Health Insurance Support for Preventive Services Expands Coverage and Reduces Out-of-Pocket Burden
    • Emergence of Digital Biomarkers and Continuous Glucose Monitoring Systems Sustains Innovation in Preventive Health Monitoring
    • Challenges in Data Privacy and Regulatory Compliance Create Demand for Secure, HIPAA-Compliant Preventive Tech Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preventive Healthcare Technologies and Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Early Detection & Screening Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Early Detection & Screening Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Early Detection & Screening Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chronic Disease Management Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chronic Disease Management Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Preventive Healthcare Technologies and Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Preventive Healthcare Technologies and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Preventive Healthcare Technologies and Services by Type - Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Preventive Healthcare Technologies and Services by Type - Percentage Breakdown of Value Sales for Early Detection & Screening Technologies, Chronic Disease Management Technologies, Vaccines and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION